ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
HotSpot Therapeutics, a biotech firm that launched last year to develop allosteric inhibitors for autoimmune and metabolic diseases, has acquired Macroceutics, a 5-year-old provider of DNA-encoded library screening technologies. HotSpot says the purchase is an outgrowth of a collaboration between the two firms. It will give HotSpot access to 1 billion drug-like molecules and a “fully-enabled” screening platform, the firm says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X